Raimar Löbenberg

Raimar Löbenberg

Chairman at DEFENCE THERAPEUTICS INC.

Net worth: 1 M $ as of 2024-04-29

58 year
Consumer Services
Health Technology

Profile

Raimar Löbenberg is the founder of the University of Alberta, where he holds the title of Professor-Pharmacy & Pharmaceutical since 2000.
He is also the founder of RS Therapeutics, Inc. Dr. Löbenberg's current jobs include Chairman at Defence Therapeutics Inc since 2021, Independent Director at BioNxt Solutions, Inc. since 2018, and Co-Managing Director at Vektor Pharma TF GmbH.
His former job includes being the President of the Canadian Society for Pharmaceutical Sciences from 2014 to 2015.
Dr. Löbenberg's education includes a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main and an undergraduate degree from The Johannes Gutenberg University of Mainz.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-02 5,000,000 ( 4.72% ) 1 M $ 2024-04-29
2023-11-01 100,000 ( 0.22% ) 87 700 $ 2024-04-29

Raimar Löbenberg active positions

CompaniesPositionStart
BIONXT SOLUTIONS INC. Director/Board Member 2018-12-09
DEFENCE THERAPEUTICS INC. Chairman 2021-01-04
University of Alberta Founder 1999-12-31
RS Therapeutics, Inc. Founder -
Chief Executive Officer -
All active positions of Raimar Löbenberg

Former positions of Raimar Löbenberg

CompaniesPositionEnd
Canadian Society for Pharmaceutical Sciences President 2014-12-31
See the detail of Raimar Löbenberg's experience

Training of Raimar Löbenberg

Johann Wolfgang Goethe-Universität Frankfurt am Main Doctorate Degree
The Johannes Gutenberg University of Mainz Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Raimar Löbenberg's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
DEFENCE THERAPEUTICS INC.

Health Technology

Private companies4
Canadian Society for Pharmaceutical Sciences

BioNxt Solutions, Inc.

RS Therapeutics, Inc.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Raimar Löbenberg